180 related articles for article (PubMed ID: 8589464)
21. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model.
Lin PH; Chen C; Bush RL; Yao Q; Lumsden AB; Hanson SR
J Vasc Surg; 2004 Jun; 39(6):1322-8. PubMed ID: 15192575
[TBL] [Abstract][Full Text] [Related]
22. Failure of glow-discharge polymerization onto woven Dacron to improve performance of hemodialysis grafts.
Farmer DL; Goldstone J; Lim RC; Reilly LM
J Vasc Surg; 1993 Oct; 18(4):570-5; discussion 575-6. PubMed ID: 8411464
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.
Luo Z; Akita GY; Date T; Treleaven C; Vincent KA; Woodcock D; Cheng SH; Gregory RJ; Jiang C
Circulation; 2005 Apr; 111(13):1679-84. PubMed ID: 15781730
[TBL] [Abstract][Full Text] [Related]
24. Polytetrafluoroethylene graft survival in hemodialysis.
Munda R; First MR; Alexander JW; Linnemann CC; Fidler JP; Kittur D
JAMA; 1983 Jan; 249(2):219-22. PubMed ID: 6848807
[TBL] [Abstract][Full Text] [Related]
25. Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts.
Gradzki R; Dhingra RK; Port FK; Roys E; Weitzel WF; Messana JM
Am J Kidney Dis; 2001 Dec; 38(6):1240-4. PubMed ID: 11728956
[TBL] [Abstract][Full Text] [Related]
26. Prevention of neointimal hyperplasia associated with modified stretch expanded polytetrafluoroethylene hemodialysis grafts (Gore) in an experimental preclinical study in swine.
Gessaroli M; Bombardi C; Giunti M; Bacci ML
J Vasc Surg; 2012 Jan; 55(1):192-202. PubMed ID: 21944911
[TBL] [Abstract][Full Text] [Related]
27. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
[TBL] [Abstract][Full Text] [Related]
28. Patency of Wallstents placed across the venous anastomosis of hemodialysis grafts after percutaneous recanalization.
Patel RI; Peck SH; Cooper SG; Epstein DM; Sofocleous CT; Schur I; Falk A
Radiology; 1998 Nov; 209(2):365-70. PubMed ID: 9807560
[TBL] [Abstract][Full Text] [Related]
29. Comparison of straight and Venaflo-type cuffed arteriovenous ePTFE grafts in an animal study.
Heise M; Husmann I; Grüneberg AK; Knobel A; Kirschner P; Heidenhain C
J Vasc Surg; 2011 Jun; 53(6):1661-7. PubMed ID: 21459546
[TBL] [Abstract][Full Text] [Related]
30. Stent graft versus balloon angioplasty for failing dialysis-access grafts.
Haskal ZJ; Trerotola S; Dolmatch B; Schuman E; Altman S; Mietling S; Berman S; McLennan G; Trimmer C; Ross J; Vesely T
N Engl J Med; 2010 Feb; 362(6):494-503. PubMed ID: 20147715
[TBL] [Abstract][Full Text] [Related]
31. Paclitaxel coating on the terminal portion of hemodialysis grafts effectively suppresses neointimal hyperplasia in a porcine model.
Baek I; Hwang J; Park J; Kim H; Park JS; Kim DJ
J Vasc Surg; 2015 Jun; 61(6):1575-82.e1. PubMed ID: 24581482
[TBL] [Abstract][Full Text] [Related]
32. Use of PTFE stent grafts for hemodialysis-related central venous occlusions: intermediate-term results.
Kundu S; Modabber M; You JM; Tam P; Nagai G; Ting R
Cardiovasc Intervent Radiol; 2011 Oct; 34(5):949-57. PubMed ID: 21069331
[TBL] [Abstract][Full Text] [Related]
33. Vascular access outcomes and medication use: a USRDS study.
Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
[TBL] [Abstract][Full Text] [Related]
34. Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access.
Weiss MF; Scivittaro V; Anderson JM
Am J Kidney Dis; 2001 May; 37(5):970-80. PubMed ID: 11325679
[TBL] [Abstract][Full Text] [Related]
35. Understanding the pathophysiology of hemodialysis access problems as a prelude to developing innovative therapies.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Nat Clin Pract Nephrol; 2008 Nov; 4(11):628-38. PubMed ID: 18813234
[TBL] [Abstract][Full Text] [Related]
36. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
37. Suppression of neointimal hyperplasia by sirolimus-eluting expanded polytetrafluoroethylene (ePTFE) haemodialysis grafts in comparison with paclitaxel-coated grafts.
Baek I; Bai CZ; Hwang J; Park J; Park JS; Kim DJ
Nephrol Dial Transplant; 2012 May; 27(5):1997-2004. PubMed ID: 22058173
[TBL] [Abstract][Full Text] [Related]
38. High incidence of perigraft seroma formation with gelatin-coated polytetrafluoroethylene grafts.
Ladenheim ED; Lum C; Chadwick N; Agrawal S
Semin Dial; 2012; 25(6):689-92. PubMed ID: 22686492
[TBL] [Abstract][Full Text] [Related]
39. Hemodialysis vascular access dysfunction: molecular mechanisms and treatment.
Mima A
Ther Apher Dial; 2012 Aug; 16(4):321-7. PubMed ID: 22817119
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor-alpha -308 gene polymorphism is associated with synthetic hemodialysis graft failure.
Ram S; Bass K; Abreo K; Baier RJ; Kruger TE
J Investig Med; 2003 Feb; 51(1):19-26. PubMed ID: 12580317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
